Medical Training AIBiomarker-Guided Treatment Decisions
You'll be able to select the right biomarker test, interpret results in context, and use them to guide and monitor treatment decisions.
What this track covers
This track covers how to apply biomarkers across cardiology, oncology, and rheumatology to inform diagnosis, treatment selection, and monitoring. It spans biomarker validation and clinical utility, companion diagnostics tied to specific therapies, and interpretation of cardiovascular and inflammatory marker panels.
What you will practice
- Distinguish diagnostic, prognostic, and predictive biomarkers before applying results to a treatment decision
- Match a companion diagnostic requirement to the therapy it gates
- Interpret troponin and BNP/NT-proBNP trends in the context of a clinical presentation
- Weigh CRP, ESR, and autoantibody results when assessing disease activity
- Use serial biomarker measurements to judge treatment response and decide whether to adjust therapy
Simulator scenario
A patient with new symptoms and an ambiguous initial biomarker panel, where the clinician must decide what additional testing to order and how to adjust the treatment plan as serial results come in.
Board question topics
- Biomarker validation levels and clinical utility
- Companion diagnostic requirements for targeted therapies
- Cardiovascular biomarker interpretation and risk stratification
- Using inflammatory markers to guide treatment adjustments
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free